S2Medical AB (publ) (S2M.ST)
S2Medical AB (publ) operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Linköping, OG, SE. The stock last traded at $0.01, down 3.70% on the session, giving a market capitalisation of $6.3M. Its beta of 2.33 implies it has historically moved more than the broad market.
S2Medical AB (publ) focuses on the development, production, and commercialization of advanced wound care solutions, specifically targeting burns and chronic wounds. Their product range features INSTAQRETT, a sterile, disposable tool for mechanical debridement; EPIPROTECT SafeStop, designed to control bleeding; and Instagraft, a single-use medical device for treating complex and prolonged wounds. The company also supplies EPIPROTECT tissue replacement products and INSTABIND-branded bandages, which are known for being washable, waterproof, and self-adhesive. Furthermore, S2Medical distributes Silverlon dressings, which facilitate the delivery of silver ions to the wound. In addition to its product offerings, the company operates specialized wound healing centers known as S2Clinic. Founded in 2013, S2Medical is headquartered in Linköping, Sweden.
S2Medical AB (publ) is most often compared with the following Healthcare names: